News:
Stem cell biotech stays afloat
Posted by Bob Grant
[Entry posted at 7th October 2008 09:50 PM GMT]
Comment on this news story   
Embryonic stem cell biotech company Advanced Cell Technology (ACT), announced today (Oct. 7) that it will be selling off $500,000 in convertible bonds in the next three months, following the company's ...

For FREE access to this news story and more, you must register.

Not yet registered? Get free access
 

The article you are attempting to read is only available to registered users of The Scientist. Registration is FREE and only takes a few seconds.

 
 

Email

Password

> Forgot Password?
> FAQ
> Subscribe

 
Not yet registered? Get free access
 

Create your MyScientist account and access all of The Scientist's free content, tools and life science email newsletters, including:

 

> The current month’s print issue

> Daily & Bi-weekly e-mail newsletters

> Newsblogs with breaking headlines

> The Scientist Community

> Exclusive web extras

> The Scientist Careers

 

Premium content from The Scientist Archive, a comprehensive resource of over 22 years of past life science coverage, is available only by subscription. Subscribe today and get unlimited access

 

 
LATEST NEWS